Navigation Links
Dr. Michael Merzenich Joins Venerable Short List Honored for Cutting-Edge Neuroscientific Research

SAN FRANCISCO, Oct. 12 /PRNewswire/ -- Dr. Michael Merzenich, PhD - renowned neuroscientist, university professor, cochlear implant inventor, brain plasticity expert and tech entrepreneur - was formally inducted in the Institute of Medicine (IOM) today in Washington, D.C. Also a member of the National Academy of Sciences, Dr. Merzenich is one of a small group of scientists and doctors in the U.S. who have been selected for recognition by both institutions. IOM members are elected by their peers through a selective process that recognizes people who have made major contributions to the advancement of the medical sciences, health care, and public health.

"I am, of course, delighted by the generosity of my colleagues to be chosen for this honor," said Dr. Merzenich, currently co-founder and Chief Scientific Officer at Posit Science. "The discovery of the brain's ability to rewire itself has been at the core of my life's work, and I have been very fortunate to have worked with some of the brightest scientists, technologists and clinicians in the world with the mission of applying our science to improve the quality of life for others."

Dr. Merzenich is currently working with scientists and doctors at the University of California, San Francisco (UCSF) on mental health solutions, including recent promising studies on the use of brain fitness training conducted in aging, brain-injured, autistic and schizophrenic patient populations.

"Mike has been a pioneer and a leader in demonstrating that the brain function and wiring is sensitive to neural activity. His basic work has elucidated mechanisms underlying this plasticity, and his translational work has illuminated the possible ways medicine can intervene to ameliorate brain disorders," said Dr. John Rubenstein, MD, PhD, distinguished professor in Child Psychiatry at UCSF and an IOM member. "His work has revolutionized the way we view the brain's plasticity and his latest work in mental disorders illustrates his sincere dedication to alleviate human suffering."

For more than three decades, Dr. Merzenich has been a leading pioneer in brain plasticity research. In 1971, Dr. Merzenich joined the faculty of UCSF and started the Keck Center for Integrative Neurosciences. In the late 1980's, Dr. Merzenich was part of the team that invented the cochlear implant. In 1990 he became a full professor at UCSF in Neuroscience, Physiology, Biomedical Engineering and Otolaryngology. He is currently Professor Emeritus in the departments of Otolaryngology and Physiology at UCSF.

In 1996, Dr. Merzenich was the founding CEO of Scientific Learning Corporation, which markets and distributes software that applies principles of brain plasticity to assist children with language learning and reading. In 2003, Posit Science was begun by Dr. Merzenich and Jeff Zimman to take neuroscience out of the labs and put it into the hands of consumers with engaging adaptive brain fitness software.

Dr. Merzenich has published more than 200 articles, including many in leading peer-reviewed journals (such as Science and Nature), received numerous awards and prizes (including the Ipsen Prize, Zulch Prize, Thomas Alva Edison Patent Award and Purkinje Medal) and has been granted more than 50 patents for his work.

"Mike's work not only improves cognitive function across a wide array of disorders and conditions," said Zimman, Chairman of Posit Science. "Results from his studies have also been shown to significantly improve broad measures of overall health such as health-related quality-of-life and performance of everyday tasks."

Dr. Merzenich holds a BS in General Science from the University of Portland and a PhD in Physiology from Johns Hopkins University, with a Neuroscience fellowship from the University of Wisconsin at Madison. To read his blog, go to

About Posit Science

Posit Science is the leader in delivering clinically proven brain fitness software into the hands of consumers. The company combines breakthrough research and a focus on great customer experiences to create products that are engaging and help users think faster, focus better and remember more. Staff neuroscientists collaborate with more than 50 scientists from leading research institutions as well as engineers and product marketers to design, build and test our computer-based programs. Posit Science products are available online, through health, long term care and auto insurers, and from public television's "The Brain Fitness Program" documentary. For more information, visit or call 1-866-599-6463.

Posit Science is a registered trademark of Posit Science Corp. Other company and product names may be trademarks of their respective owners.

SOURCE Posit Science

SOURCE Posit Science
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
2. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
3. Genstar Names Michael Hurt to Its Strategic Advisory Board
4. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
5. MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Companys Scientific Advisory Board
6. Pharmasset Appoints Michael Rogers as Chief Development Officer
7. The Michael J. Fox Foundation Awards $2 Million to Shed Light on Role of LRRK2 and Alpha-Synuclein Genes in Parkinsons Disease
8. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
9. Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
10. Dr Michael Rosenblatt Appointed Non-Executive Director at Shire
11. Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals Board of Directors
Post Your Comments:
(Date:11/24/2015)... CITY , Nov. 24, 2015 /PRNewswire/ - ... "Company") announced today that the remaining 11,000 post-share ... Share Purchase Warrants (the "Series B Warrants") subject ... were exercised on November 23, 2015, which will ... Shares.  After giving effect to the issuance of ...
(Date:11/24/2015)... ... , ... InSphero AG, the leading supplier of easy-to-use solutions for production, culture, ... serve as Chief Operating Officer. , Having joined InSphero in November 2013 ... was promoted to Head of InSphero Diagnostics in 2014. There she has built ...
(Date:11/24/2015)... Capricor Therapeutics, Inc. (NASDAQ: ... development and commercialization of first-in-class therapeutics, today announced that ... scheduled to present at the 2015 Piper Jaffray Healthcare ... at The Lotte New York Palace Hotel in ... . --> . ...
(Date:11/24/2015)... MUNICH and NEW YORK , ... irst investment by Bristol-Myers Squibb in a ... Bristol-Myers Squibb Company in which the companies ... products in immuno-oncology and other areas of unmet medical need. ... Squibb in LSP 5, the latest LSP fund. This is ...
Breaking Biology Technology:
(Date:11/2/2015)... PARK, Calif. , Nov. 2, 2015  SRI ... $9 million to provide preclinical development services to the ... the contract, SRI will provide scientific expertise, modern testing ... wide variety of preclinical pharmacology and toxicology studies to ... --> The PREVENT Cancer Drug Development ...
(Date:10/29/2015)... 29, 2015 Daon, a global leader in ... released a new version of its IdentityX Platform ... North America have already installed IdentityX v4.0 ... a FIDO UAF certified server component as ... activate FIDO features. These customers include some of the ...
(Date:10/29/2015)... , October 29, 2015 ... biometric authentication company focused on the growing mobile ... wallet announces that StackCommerce, a leading marketplace to ... featuring the Wocket® smart wallet on StackSocial for ... ) ("NXT-ID" or the "Company"), a biometric authentication ...
Breaking Biology News(10 mins):